Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S3. https://doi.org/10.25251/skin.2.supp.3